Ascentgene
UEI: FFJZXSPAFDL3
• CAGE: 559V9
Overview
Awardee Type
Parent
Federal Capability Statement
1. manufacture of recombinant proteins, monoclonal antibodies, virus-like particles for research and drug development
2. cell line development for research and therapeutic purposes
Keywords
Protein production, stable cell lines, therapeutic proteins, antibodies, vaccines
SBA Special Equipment
AG-CHO cell line for high expression of proteins, monoclonal antibodies and immunotoxins
Website
Headquarters
Gaithersburg, MD
United States
United States
Most Recent Award
Oct. 29, 2013
Calculating
Federal contract recipient
ASCENTGENE INC
(UEI FFJZXSPAFDL3, CAGE 559V9)
is headquartered in Gaithersburg MD.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in June 2008 and
federally registered in
July 2008.
Federal Award Analysis
Ascentgene federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ASCENTGENE INC
UEI
FFJZXSPAFDL3
CAGE Code
559V9
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Minority Owned Business
Minority Owned Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 1, 2008
Initial Registration
July 23, 2008
Last Registration
Aug. 20, 2025
Registration Activation
Aug. 20, 2025
Registration Expiration
Aug. 18, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
MD
Country of Incorporation
USA
Employees
<500
Disaster Registry
Nationwide
Accepts Credit Cards
Yes